Literature DB >> 32202233

B4GALT3 promotes cell proliferation and invasion in glioblastoma.

Tao Wu1, Yifei Li1, Baodong Chen1.   

Abstract

Background: β-1, 4-galactosyltransferase III (B4GALT3) plays an important role in development tumourigenesis. But its role in human glioblastoma (GBM) is still unknown.Materials and methods: To perform gain-of-function and loss-of-function experiment, we transfected siRNA or vector into GBM cells. CCK-8, EdU staining, transwell, western blot, immunofluorescence staining were applied to perform phenotype and mechanism experiment. GlioVis platform was used to analyze B4GALT3 expression from TCGA datasets.
Results: B4GALT3 is upregulated in glioblastoma and predicts poor prognosis. Upregulation of B4GALT3 promotes GBM cell proliferation and invasion while the downregulation of B4GALT3 reduces GBM cell proliferation and invasion. B4GALT3 regulates cell proliferation and invasion via β-catenin and vimentin. B4GALT3 correlates with cell invasion markers in clinical samples.
Conclusion: B4GALT3 might be a potential molecular therapeutic target of glioblastoma.

Entities:  

Keywords:  B4GALT3; glioblastoma; vimentin; β-catenin

Mesh:

Substances:

Year:  2020        PMID: 32202233     DOI: 10.1080/01616412.2020.1740465

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Finding New Ways How to Control BACE1.

Authors:  Jarmila Nahálková
Journal:  J Membr Biol       Date:  2022-03-19       Impact factor: 1.843

Review 2.  Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models.

Authors:  Michela Pucci; Martina Duca; Nadia Malagolini; Fabio Dall'Olio
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer.

Authors:  Rachel Topno; Ibha Singh; Manoj Kumar; Pallavi Agarwal
Journal:  BMC Cancer       Date:  2021-03-04       Impact factor: 4.430

4.  Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm.

Authors:  Zhiyang Zhou; Tao Wang; Yao Du; Junping Deng; Ge Gao; Jiangnan Zhang
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

5.  Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.

Authors:  Yunlong Bi; Yu Jing; Lingling Guo
Journal:  Front Genet       Date:  2022-10-03       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.